Search Results
Dec 15, 2025, 17:41 ET Piramal Pharma Solutions démontre son engagement envers l'excellence avec un taux de recommandation net exceptionnel
commercialise des produits de consommation et de bien-être en vente libre. En outre, l'une des entreprises associées à PPL, AbbVie Therapeutics India Private Limited, une coentreprise entre AbbVie et PPL, s'est imposée comme l'un des leaders du marché pharmaceutique indien dans le domaine des thérapies ophtalmologiques.
More news about: Piramal Pharma Solutions
Dec 15, 2025, 17:30 ET Ovintiv Enters Into Agreement for Cedar LNG Capacity
2025 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) ("Ovintiv" or the "Company") and a subsidiary of Pembina Pipeline Corporation ("Pembina") (TSX: PPL; NYSE: PBA) today announced the signing of a 12-year agreement (the "Agreement") for 0.5 million tonnes per annum ("mtpa") of Pembina's liquefaction
More news about: Ovintiv Inc.
Dec 15, 2025, 08:50 ET Piramal Pharma Solutions demuestra su compromiso con la excelencia con un Net Promoter Score excepcional
Además, una de las empresas asociadas de PPL, AbbVie Therapeutics India Private Limited, una empresa conjunta entre AbbVie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL tiene una inversión minoritaria estratégica
More news about: Piramal Pharma Solutions
Dec 15, 2025, 01:00 ET Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
LimitedPiramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Dec 15, 2025, 00:49 ET Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
LimitedPiramal Pharma Limited (PPL), (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Dec 02, 2025, 08:30 ET WIRES Announces 2026 Officers and Board of Directors
service at the end of 2025. WIRES 2026 Board of Directors:Amanda Rumsey, Manager, RTO and Federal Regulatory Policy, PPLJodi Moskowitz, VP Regulatory, Deputy General Counsel & RTO Strategy Officer, PSEGStacey Burbure, Senior Vice President, Transmission
More news about: WIRES
Nov 27, 2025, 10:50 ET Piramal Pharma Solutions obtient la conformité réglementaire pour les impuretés de nitrosamine
XÀ propos de Piramal Pharma LimitedPiramal Pharma Limited (PPL, NSE : PPLPHARMA I BSE : 543635) propose une gamme de produits et de services différenciés à partir de ses 17* sites de développement et de fabrication
More news about: Piramal Pharma Solutions
Nov 27, 2025, 10:46 ET Piramal Pharma Solutions erfüllt regulatorische Anforderungen hinsichtlich Nitrosaminverunreinigungen
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 27, 2025, 06:33 ET Piramal Pharma Solutions ottiene la conformità normativa per le impurità nitrosammine
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL inoltre detiene una partecipazione strategica
More news about: Piramal Pharma Solutions
Nov 27, 2025, 06:30 ET Piramal Pharma Solutions logra el cumplimiento normativo para impurezas de nitrosamina
Además, una de las empresas asociadas de PPL, Abbvie Therapeutics India Private Limited, una empresa conjunta entre Abbvie y PPL, se ha consolidado como uno de los líderes del mercado en el área de terapia oftalmológica en el mercado farmacéutico indio. Asimismo, PPL tiene una inversión minoritaria estratégica
More news about: Piramal Pharma Solutions
Nov 26, 2025, 14:19 ET Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 26, 2025, 14:13 ET Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
LimitedPiramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 21, 2025, 07:30 ET PPL to Pay Quarterly Stock Dividend Jan 2, 2026
About PPLPPL Corporation (NYSE: PPL), headquartered in Allentown, Pennsylvania, is a leading U.S. energy company focused on providing electricity and natural gas safely,
More news about: PPL Services Corporation
Nov 19, 2025, 23:43 ET L'usine de bioconjugués de Piramal Pharma Solutions à Grangemouth, au Royaume-Uni, reçoit des certificats de BPF de la MHRA mis à jour
X À propos de Piramal Pharma Limited Piramal Pharma Limited (PPL) (NSE : PPLPHARMA) (BSE : 543635) propose une gamme de produits et de services différenciés à partir de ses 17* sites de développement et de fabrication
More news about: Piramal Pharma Solutions
Nov 19, 2025, 20:22 ET PPL Capital Funding, Inc. announces pricing of $1 billion of 3.000% Exchangeable Senior Notes
ALLENTOWN, Pa., Nov. 19, 2025 /PRNewswire/ -- PPL Capital Funding, Inc. ("PPL Capital Funding"), a wholly-owned subsidiary of PPL Corporation (NYSE: PPL), announced today the pricing of $1 billion aggregate principal amount of its 3.000% Exchangeable
More news about: PPL Services Corporation
Nov 19, 2025, 15:50 ET La planta de bioconjugados de Piramal Pharma Solutions en Grangemouth recibe certificados GMP de la MHRA
Piramal Pharma Limited (PPL, NSE: PPLPHARMA | BSE: 543635) ofrece una cartera de productos y servicios diferenciados a través de sus 17* centros de desarrollo y fabricación a nivel mundial y una red de distribución global presente en más de 100 países. PPL incluye Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 19, 2025, 15:47 ET Die Biokonjugat-Anlage von Piramal Pharma Solutions in Grangemouth, Großbritannien, erhält aktualisierte MHRA-GMP-Zertifikate
Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) ( BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 19, 2025, 15:44 ET Lo stabilimento di bioconiugati di Piramal Pharma Solutions a Grangemouth, nel Regno Unito, riceve i certificati GMP MHRA aggiornati
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL detiene inoltre una partecipazione strategica
More news about: Piramal Pharma Solutions
Nov 19, 2025, 06:50 ET PPL Capital Funding, Inc. announces proposed private placement of $1 billion of Exchangeable Senior Notes
ALLENTOWN, Pa., Nov. 19, 2025 /PRNewswire/ -- PPL Capital Funding, Inc. ("PPL Capital Funding"), a wholly-owned subsidiary of PPL Corporation (NYSE: PPL), announced today that it intends to offer, subject to market conditions and other factors, $1 billion
More news about: PPL Services Corporation
Nov 19, 2025, 02:48 ET Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) ( BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions
Nov 19, 2025, 02:41 ET Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Limited (PPL) (NSE: PPLPHARMA) ( BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes
More news about: Piramal Pharma Solutions
Nov 05, 2025, 12:57 ET Piramal Pharma Limited Announces Results for Q2 and H1 FY26
Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 171 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Limited
Nov 05, 2025, 07:30 ET PPL Corporation reports third-quarter 2025 results; narrows earnings forecast and reaffirms growth targets
of this news release for a complete reconciliation of the earnings forecast. About PPLPPL Corporation (NYSE: PPL), headquartered in Allentown, Pennsylvania, is a leading U.S. energy company focused on providing electricity and natural gas safely,
More news about: PPL Services Corporation
Oct 30, 2025, 23:46 ET Piramal Pharma Solutions formalizza la partnership stretta con IntoCell espandendo la propria piattaforma Payload-Linker e le capacità di sviluppo di bioconiugati
Inoltre una delle società associate di PPL, Abbvie Therapeutics India Private Limited – una joint venture tra Abbvie e PPL – si è affermata come una delle imprese principali nel settore farmaceutico indiano, specificamente nell'area della terapia oftalmologica. PPL inoltre detiene una partecipazione strategica
More news about: Piramal Pharma Solutions
Oct 30, 2025, 19:00 ET Piramal Pharma Solutions formalisiert Partnerschaft mit IntoCell und erweitert seine Payload-Linker-Plattform und Biokonjugat-Kapazitäten
Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635) bietet über seine 17* weltweiten Entwicklungs- und Produktionsstätten und ein weltweites Vertriebsnetz in über 100 Ländern ein Portfolio differenzierter Produkte und Dienstleistungen an. Zu PPL gehören Piramal Pharma Solutions (PPS),
More news about: Piramal Pharma Solutions